Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Clarivate Plc stock logo
CLVT
Clarivate
$4.40
+2.3%
$3.89
$3.04
$7.15
$3.01B1.495.23 million shs4.79 million shs
ICON Public Limited stock logo
ICLR
ICON Public
$132.08
+1.0%
$153.11
$127.51
$347.72
$10.67B1.231.04 million shs1.89 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$306.62
+0.2%
$303.64
$250.05
$459.77
$8.81B1.55351,066 shs206,179 shs
Stantec Inc. stock logo
STN
Stantec
$101.76
+0.3%
$87.37
$73.18
$103.32
$11.61B0.98142,563 shs340,542 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Clarivate Plc stock logo
CLVT
Clarivate
+2.33%-0.90%+30.10%-7.47%-25.86%
ICON Public Limited stock logo
ICLR
ICON Public
+1.02%-5.99%-5.15%-30.96%-58.56%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
+0.21%-1.14%+3.49%-10.87%-22.81%
Stantec Inc. stock logo
STN
Stantec
+0.27%+7.42%+16.54%+30.11%+27.33%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Clarivate Plc stock logo
CLVT
Clarivate
1.7682 of 5 stars
1.81.00.00.02.53.31.9
ICON Public Limited stock logo
ICLR
ICON Public
4.4657 of 5 stars
4.35.00.00.01.53.32.5
Medpace Holdings, Inc. stock logo
MEDP
Medpace
4.7778 of 5 stars
3.11.00.04.63.75.02.5
Stantec Inc. stock logo
STN
Stantec
2.3791 of 5 stars
0.02.03.30.03.31.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Clarivate Plc stock logo
CLVT
Clarivate
1.67
Reduce$5.0013.64% Upside
ICON Public Limited stock logo
ICLR
ICON Public
2.60
Moderate Buy$213.0861.33% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.23
Hold$349.3013.92% Upside
Stantec Inc. stock logo
STN
Stantec
3.00
BuyN/AN/A

Current Analyst Ratings Breakdown

Latest CLVT, STN, ICLR, and MEDP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/16/2025
Stantec Inc. stock logo
STN
Stantec
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/16/2025
Stantec Inc. stock logo
STN
Stantec
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/15/2025
ICON Public Limited stock logo
ICLR
ICON Public
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$200.00 ➝ $173.00
5/7/2025
Stantec Inc. stock logo
STN
Stantec
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/2/2025
ICON Public Limited stock logo
ICLR
ICON Public
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$165.00 ➝ $155.00
5/2/2025
ICON Public Limited stock logo
ICLR
ICON Public
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $160.00
5/2/2025
ICON Public Limited stock logo
ICLR
ICON Public
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$192.00 ➝ $160.00
4/29/2025
ICON Public Limited stock logo
ICLR
ICON Public
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$265.00 ➝ $150.00
4/23/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$333.00 ➝ $300.00
4/23/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$340.00 ➝ $313.00
4/22/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform
(Data available from 5/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Clarivate Plc stock logo
CLVT
Clarivate
$2.53B1.19$1.52 per share2.89$7.43 per share0.59
ICON Public Limited stock logo
ICLR
ICON Public
$8.19B1.30$12.84 per share10.29$115.44 per share1.14
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.16B4.09$12.40 per share24.72$27.10 per share11.31
Stantec Inc. stock logo
STN
Stantec
$7.70B1.51$5.95 per share17.10$17.90 per share5.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Clarivate Plc stock logo
CLVT
Clarivate
-$911.20M-$0.97N/A6.47N/A-24.90%9.10%3.93%8/5/2025 (Estimated)
ICON Public Limited stock logo
ICLR
ICON Public
$612.34M$9.1813.868.641.869.56%11.81%6.65%7/23/2025 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$404.39M$13.1024.2822.453.8119.17%51.48%20.47%7/28/2025 (Estimated)
Stantec Inc. stock logo
STN
Stantec
$245.35M$2.4246.2529.50N/A4.78%16.57%6.99%8/6/2025 (Estimated)

Latest CLVT, STN, ICLR, and MEDP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Stantec Inc. stock logo
STN
Stantec
$0.79$0.81+$0.02$0.61$1.54 billion$1.08 billion
4/30/2025Q1 2025
ICON Public Limited stock logo
ICLR
ICON Public
$3.17$3.19+$0.02$1.90$2.03 billion$2.00 billion
4/29/2025Q1 2025
Clarivate Plc stock logo
CLVT
Clarivate
$0.12$0.14+$0.02-$0.15$574.03 million$593.70 million
4/21/2025Q1 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.06$3.67+$0.61$3.67$528.38 million$558.57 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Clarivate Plc stock logo
CLVT
Clarivate
N/AN/AN/AN/AN/A
ICON Public Limited stock logo
ICLR
ICON Public
N/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
Stantec Inc. stock logo
STN
Stantec
$0.620.61%+8.37%25.62%13 Years

Latest CLVT, STN, ICLR, and MEDP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/15/2025
Stantec Inc. stock logo
STN
Stantec
quarterly$0.16120.6%6/30/20256/30/20257/15/2025
2/26/2025
Stantec Inc. stock logo
STN
Stantec
quarterly$0.15740.7%3/28/20253/28/20254/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Clarivate Plc stock logo
CLVT
Clarivate
0.88
0.87
0.88
ICON Public Limited stock logo
ICLR
ICON Public
0.36
1.26
1.34
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.93
0.93
Stantec Inc. stock logo
STN
Stantec
0.54
1.42
1.42

Institutional Ownership

CompanyInstitutional Ownership
Clarivate Plc stock logo
CLVT
Clarivate
85.72%
ICON Public Limited stock logo
ICLR
ICON Public
95.61%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
Stantec Inc. stock logo
STN
Stantec
63.86%

Insider Ownership

CompanyInsider Ownership
Clarivate Plc stock logo
CLVT
Clarivate
23.18%
ICON Public Limited stock logo
ICLR
ICON Public
44.00%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.30%
Stantec Inc. stock logo
STN
Stantec
0.46%
CompanyEmployeesShares OutstandingFree FloatOptionable
Clarivate Plc stock logo
CLVT
Clarivate
11,600683.09 million548.65 millionOptionable
ICON Public Limited stock logo
ICLR
ICON Public
41,10080.76 million46.20 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
5,20028.74 million24.28 millionOptionable
Stantec Inc. stock logo
STN
Stantec
26,000114.07 million113.54 millionOptionable

Recent News About These Companies

Atb Cap Markets Issues Positive Outlook for Stantec Earnings
Stifel Canada Has Optimistic Outlook of Stantec Q3 Earnings
National Bank Financial Forecasts Stantec Q3 Earnings
Desjardins Has Positive Outlook for Stantec Q2 Earnings
Stantec (NYSE:STN) Upgraded by StockNews.com to Strong-Buy Rating
Equities Analysts Offer Predictions for Stantec Q2 Earnings
New Strong Buy Stocks for May 16th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Clarivate stock logo

Clarivate NYSE:CLVT

$4.40 +0.10 (+2.33%)
As of 05/20/2025 03:59 PM Eastern

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

ICON Public stock logo

ICON Public NASDAQ:ICLR

$132.08 +1.33 (+1.02%)
As of 05/20/2025 04:00 PM Eastern

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Medpace stock logo

Medpace NASDAQ:MEDP

$306.62 +0.64 (+0.21%)
As of 05/20/2025 04:00 PM Eastern

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Stantec stock logo

Stantec NYSE:STN

$101.76 +0.28 (+0.28%)
As of 05/20/2025 03:58 PM Eastern

Stantec Inc. provides professional services in the areas of infrastructure and facilities to the public and private sectors in Canada, the United States, and internationally. It offers evaluation, planning, and designing infrastructure solutions; solutions for sustainable water resources, planning, management, and infrastructure; environmental services; integrated architecture, engineering, interior design, and planning solutions for buildings; and energy and resources solutions. The company also provides consulting services in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics. In addition, it offers planning and design services to clients in residential, logistics, retail, infrastructure, energy, higher education, and urban regeneration sectors; architectural and interior design, and planning services in the science and technology, commercial workplace, higher education, residential, and hospitality markets. Further, the company provides transportation advisory, transport engineering, and technical design; project delivery consultancy services for mining, resources, and industrial infrastructure projects; paleontological and archaeological services for the rail, transportation, water, and power and energy sectors; and environmental and cultural resource compliance services. Additionally, it offers consulting services in sustainable building design, energy infrastructure upgrades, sustainable district heating network, and e-mobility; and planning, design, construction administration, commissioning, maintenance, decommissioning, and remediation services. The company was formerly known as Stanley Technology Group Inc. and changed its name to Stantec Inc. in October 1998. Stantec Inc. was founded in 1954 and is headquartered in Edmonton, Canada.